Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer is a research paper published in Cancer Discovery (2022). On theSindex it has a DataRank of 2.5. It has been cited 140 times, with 110 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.742
From this paper's citation signal
Citation Network Contribution
1.8
From 83 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 110 citers.
NCI NIH HHS
Grant: P30 CA125123
NCI NIH HHS
Grant: T32 CA203690
NCI NIH HHS
Grant: U01 CA214125
NCI NIH HHS
Grant: U24 CA210986
NCI NIH HHS
Grant: K12 CA167540
NCI NIH HHS
Grant: P50 CA186784
NCI NIH HHS
Grant: U24 CA270823
NCI NIH HHS
Grant: U24 CA271075
NCI NIH HHS
Grant: U54 CA224076
NIH HHS
Grant: R03 OD032626
NCI NIH HHS
Grant: U24 CA160034
NCI NIH HHS
Grant: U24 CA210954
NCI NIH HHS
Grant: K22 CA241113
NCI NIH HHS
Grant: U54 CA224083
NIH HHS
Grant: S10 OD028671
NCI NIH HHS
Grant: U24 CA210979
NCI NIH HHS
Grant: U24 CA226110
National Institutes of Health
Grant: 5U24CA210954-04
iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTAC
National Institutes of Health
Grant: 1R03OD032626-01
Using phosphorylation signatures of drug perturbagens to identify exercise-mimetic compounds
National Institutes of Health
Grant: 3P50CA186784-10S1
Translational Research in Breast Cancer
National Institutes of Health
Grant: 5T32CA203690-04
Translational Breast Cancer Research Training Program
National Institutes of Health
Grant: 1S10OD028671-01
S10 Shared Instrument Grant - Leica Aperio Digital Scanner GT450
National Institutes of Health
Grant: 1U24CA210979-01
Integrated high throughput proteogenomic data analysis center for CPTAC
National Institutes of Health
Grant: 5U24CA210986-02
Center of Excellence for High Throughput Proteogenomic Characterization
National Institutes of Health
Grant: 3P30CA125123-09S3
Baylor College of Medicine Cancer Center
National Institutes of Health
Grant: 3U54CA224076-01S2
PDX Trial Center for Breast Cancer Therapy
National Institutes of Health
Grant: 3U54CA224083-04S1
Washington University PDX Development and Trial Center - Evaluation of Abemaciclib in Combination with Olaparib in Ovarian Cancer and Breast Cancer Patient-derived Xenograft Models
National Institutes of Health
Grant: 5U01CA214125-03
MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS
National Institutes of Health
Grant: 5K12CA167540-10
Washington University Paul Calabresi K12 Career Development Award for Clinical Oncology
National Institutes of Health
Grant: 5U24CA226110-05
INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER
National Institutes of Health
Grant: 5U24CA160034-02
Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers
National Cancer Institute
Cancer Prevention and Research Institute of Texas
FWCI
10.60
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals